803 related articles for article (PubMed ID: 22925498)
1. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
Lai MC; Kuo YC; Kuo HC
Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
[TBL] [Abstract][Full Text] [Related]
2. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?
Daha LK; Riedl CR; Lazar D; Hohlbrugger G; Pflüger H
Eur Urol; 2005 Mar; 47(3):393-7; discussion 397. PubMed ID: 15716206
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome.
Pyo JS; Cho WJ
Cell Physiol Biochem; 2016; 39(4):1618-25. PubMed ID: 27627755
[TBL] [Abstract][Full Text] [Related]
4. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin.
Welk BK; Teichman JM
Urology; 2008 Jan; 71(1):67-70. PubMed ID: 18242367
[TBL] [Abstract][Full Text] [Related]
5. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis.
Morales A; Emerson L; Nickel JC; Lundie M
J Urol; 1996 Jul; 156(1):45-8. PubMed ID: 8648835
[TBL] [Abstract][Full Text] [Related]
6. Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis.
Shao Y; Shen ZJ; Rui WB; Zhou WL
Urology; 2010 Mar; 75(3):547-50. PubMed ID: 20022087
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
8. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
9. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
Nickel JC; Hanno P; Kumar K; Thomas H
Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
[TBL] [Abstract][Full Text] [Related]
10. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
Chuang YC; Lee WC; Lee WC; Chiang PH
J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
[TBL] [Abstract][Full Text] [Related]
11. Differences in the clinical presentation of interstitial cystitis/painful bladder syndrome in patients with or without sexual abuse history.
Seth A; Teichman JM
J Urol; 2008 Nov; 180(5):2029-33. PubMed ID: 18804240
[TBL] [Abstract][Full Text] [Related]
12. Effect of supplementation with hydrogen-rich water in patients with interstitial cystitis/painful bladder syndrome.
Matsumoto S; Ueda T; Kakizaki H
Urology; 2013 Feb; 81(2):226-30. PubMed ID: 23374763
[TBL] [Abstract][Full Text] [Related]
13. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
[TBL] [Abstract][Full Text] [Related]
14. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.
Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F
J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961
[TBL] [Abstract][Full Text] [Related]
15. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
Chuang YC; Kuo HC
J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
[TBL] [Abstract][Full Text] [Related]
16. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
17. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.
Peng CH; Kuo HC
Urol Int; 2007; 78(1):78-81. PubMed ID: 17192738
[TBL] [Abstract][Full Text] [Related]
18. On- and post-treatment symptom relief by repeated instillations of heparin and alkalized lidocaine in interstitial cystitis.
Nomiya A; Naruse T; Niimi A; Nishimatsu H; Kume H; Igawa Y; Homma Y
Int J Urol; 2013 Nov; 20(11):1118-22. PubMed ID: 23432185
[TBL] [Abstract][Full Text] [Related]
19. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management.
Nickel JC; Shoskes D; Irvine-Bird K
J Urol; 2009 Jul; 182(1):155-60. PubMed ID: 19447429
[TBL] [Abstract][Full Text] [Related]
20. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome.
Nickel JC; Moldwin R; Lee S; Davis EL; Henry RA; Wyllie MG
BJU Int; 2009 Apr; 103(7):910-8. PubMed ID: 19021619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
